Old Web
English
Sign In
Acemap
>
authorDetail
>
Jiajun Liu
Jiajun Liu
Biogen Idec
Medicine
Internal medicine
Clinical trial
Clinical endpoint
Placebo
6
Papers
22
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Visual function improvements with BIIB112 (NSR-RPGR) in X-linked retinitis pigmentosa: XIRIUS (dose-expansion) and XOLARIS (natural disease progression) studies
2021
Investigative Ophthalmology & Visual Science
Robert E. MacLaren
Byron L. Lam
Andrew J. Lotery
P. E. Stanga
Assad Jalil
Mark E. Pennesi
David G. Birch
Christine N. Kay
Jiajun Liu
Eileen Liao
Lenore von Krusenstiern
Show All
Source
Cite
Save
Citations (0)
Bayesian Approaches for Handling Hypothetical Estimands in Longitudinal Clinical Trials with Gaussian Outcomes
2021
Statistics in Biopharmaceutical Research
G. Frank Liu
Jiajun Liu
Fang Chen
Roee Gutman
Kaifeng Lu
Show All
Source
Cite
Save
Citations (0)
FRI0195 EFFICACY AND SAFETY OF DAPIROLIZUMAB PEGOL (DZP) IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A RANDOMISED, PLACEBO (PBO)-CONTROLLED STUDY
2019
Annals of the Rheumatic Diseases
Richard A. Furie
Ian N. Bruce
Thomas Dörner
Manuel Gustavo Leon
Piotr Leszczyński
Murray B. Urowitz
Birgit Haier
Teri Jimenez
C. Barbey
Jiajun Liu
C. Stach
Show All
Source
Cite
Save
Citations (16)
1